EDN1 and Alzheimer disease: RAGE-dependent BBB transport of circulating Aβ results in the production of ET-1 to cause decreased CBF; infusion of either RAGE-specific IgG, soluble RAGE (as a decoy receptor), or RAGE inhibitor treatment in AD transgenic mice causes an increase in CBF and reduction in brain Aβ levels [79, 80].